The University of Wisconsin System was awarded a $592,859 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for a 4-year period starting September 15, 2024. The grant funding will support a research project titled "GENE EXPRESSION ANALYSIS OF CIRCULATING TUMOR CELLS: A NEXT-GENERATION BIOMARKER TO PREDICT IMMUNOTHERAPY RESPONSE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA." This project aims to analyze gene expression in circulating tumor cells to develop a new biomarker for predicting response to immunotherapy treatments in patients with metastatic clear cell renal cell carcinoma. The Military Medical Research and Development program supports a range of biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public.
Generated 2/25/25, 3:01 AM